Central action of benserazide after COMT inhibition demonstrated in vivo by PET
- 1 February 1991
- journal article
- research article
- Published by Springer Nature in Journal Of Neural Transmission-Parkinsons Disease and Dementia Section
- Vol. 85 (1) , 11-17
- https://doi.org/10.1007/bf01244653
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Estimation of regional cerebral utilization of [11C]-L-3, 4-dihydroxy-phenylalanine (DOPA) in the primate by positron emission tomographyActa Neurologica Scandinavica, 1992
- Regional brain kinetics of 6-fluoro-(?-11C)-L-dopa and (?-11C)-L-dopa following COMT inhibition. A study in vivo using positron emission tomographyJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1992
- Brain kinetics of L-[?-11 C]DOPA in humans studied by positron emission tomographyJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1991
- Multi-enzymatic Synthesis of beta-11C-Labelled L-Tyrosine and L-DOPA.Acta Chemica Scandinavica, 1990
- Catechol‐O‐methyltransferase‐Inhibiting Pyrocatechol Derivatives: Synthesis and Structure‐Activity StudiesHelvetica Chimica Acta, 1989
- The on-off phenomenon.Journal of Neurology, Neurosurgery & Psychiatry, 1989
- Inhibition of catechol-O-methyltransferase activity by two novel disubstituted catechols in the ratEuropean Journal of Pharmacology, 1988
- On‐off phenomenon: Relation to levodopa pharmacokinetics and pharmacodynamicsAnnals of Neurology, 1987
- Purification and Kinetic Mechanism of Human Brain Soluble Catechol-O-MethyltransferaseJournal of Neurochemistry, 1985
- 3-0-Methyldopa uptake and inhibition of L-dopa at the blood-brain barrierLife Sciences, 1975